These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 35602506)
21. A Deeper Insight into Yavas C; Ozgenturk NO; Dogan M; Gezdirici A; Keskin E; İli EG; Dogan T; Celebi E; Bender O; Un C Mol Syndromol; 2024 Feb; 15(1):1-13. PubMed ID: 38357258 [TBL] [Abstract][Full Text] [Related]
22. Alport Syndrome: Achieving Early Diagnosis and Treatment. Kashtan CE Am J Kidney Dis; 2021 Feb; 77(2):272-279. PubMed ID: 32712016 [TBL] [Abstract][Full Text] [Related]
23. Phenotype variability in a large Spanish family with Alport syndrome associated with novel mutations in COL4A3 gene. Cervera-Acedo C; Coloma A; Huarte-Loza E; Sierra-Carpio M; Domínguez-Garrido E BMC Nephrol; 2017 Oct; 18(1):325. PubMed ID: 29089023 [TBL] [Abstract][Full Text] [Related]
24. Autosomal dominant Alport syndrome linked to the type IV collage alpha 3 and alpha 4 genes (COL4A3 and COL4A4). Jefferson JA; Lemmink HH; Hughes AE; Hill CM; Smeets HJ; Doherty CC; Maxwell AP Nephrol Dial Transplant; 1997 Aug; 12(8):1595-9. PubMed ID: 9269635 [TBL] [Abstract][Full Text] [Related]
26. [Features of clinical phenotype and genotype in Alport syndrome: a monocentric study]. Sun L; Kuang X; Hao S; Wang P; Niu X; Zhu G; Zhou J; Huang W Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):114-8. PubMed ID: 25876686 [TBL] [Abstract][Full Text] [Related]
27. Genotype-phenotype correlations and nephroprotective effects of RAAS inhibition in patients with autosomal recessive Alport syndrome. Zhang Y; Böckhaus J; Wang F; Wang S; Rubel D; Gross O; Ding J Pediatr Nephrol; 2021 Sep; 36(9):2719-2730. PubMed ID: 33772369 [TBL] [Abstract][Full Text] [Related]
28. A COL4A3 gene mutation and post-transplant anti-alpha 3(IV) collagen alloantibodies in Alport syndrome. Kalluri R; van den Heuvel LP; Smeets HJ; Schroder CH; Lemmink HH; Boutaud A; Neilson EG; Hudson BG Kidney Int; 1995 Apr; 47(4):1199-204. PubMed ID: 7783419 [TBL] [Abstract][Full Text] [Related]
29. Clinical Significance of the Cystic Phenotype in Alport Syndrome. Zeni L; Mescia F; Toso D; Dordoni C; Mazza C; Savoldi G; Econimo L; Cortinovis R; Fisogni S; Alberici F; Scolari F; Izzi C Am J Kidney Dis; 2024 Sep; 84(3):320-328.e1. PubMed ID: 38514012 [TBL] [Abstract][Full Text] [Related]
30. A novel variant in the Sienes Bailo P; Bancalero Flores JL; Lahoz Alonso R; Santamaría González M; Gutiérrez Dalmau A; Álvarez de Andrés S; Izquierdo Álvarez S Adv Lab Med; 2021 Aug; 2(3):451-462. PubMed ID: 37362409 [TBL] [Abstract][Full Text] [Related]
31. A founder Plevova P; Indrakova J; Savige J; Kuhnova P; Tvrda P; Cerna D; Hilscherova S; Kudrejova M; Polendova D; Jaklova R; Langova M; Jahnova H; Lastuvkova J; Dusek J; Gut J; Vlckova M; Solarova P; Kreckova G; Kantorova E; Soukalova J; Slavkovsky R; Zapletalova J; Tichy T; Thomasova D Front Med (Lausanne); 2023; 10():1096869. PubMed ID: 36844206 [TBL] [Abstract][Full Text] [Related]
36. Case report: A novel compound heterozygous variant in the Chen S; Zhang Y; He J; Yang D Front Genet; 2024; 15():1426806. PubMed ID: 39071776 [TBL] [Abstract][Full Text] [Related]
37. Autosomal-dominant Alport syndrome: natural history of a disease due to COL4A3 or COL4A4 gene. Pescucci C; Mari F; Longo I; Vogiatzi P; Caselli R; Scala E; Abaterusso C; Gusmano R; Seri M; Miglietti N; Bresin E; Renieri A Kidney Int; 2004 May; 65(5):1598-603. PubMed ID: 15086897 [TBL] [Abstract][Full Text] [Related]